| pubmed-article:18774954 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18774954 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18774954 | lifeskim:mentions | umls-concept:C0024301 | lld:lifeskim |
| pubmed-article:18774954 | lifeskim:mentions | umls-concept:C0079744 | lld:lifeskim |
| pubmed-article:18774954 | lifeskim:mentions | umls-concept:C1510411 | lld:lifeskim |
| pubmed-article:18774954 | lifeskim:mentions | umls-concept:C1831743 | lld:lifeskim |
| pubmed-article:18774954 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18774954 | pubmed:dateCreated | 2008-11-21 | lld:pubmed |
| pubmed-article:18774954 | pubmed:abstractText | The transformation of follicular lymphoma (FL) to high-grade histology occurs in up to 70% of patients. The role of hematopoietic stem cell transplantation (HSCT) in transformed FL is poorly defined. Twenty-four FL patients with histologically confirmed transformation to diffuse large B-cell lymphoma underwent unpurged autologous HSCT at our institution. Their median age was 56 yr. The median number of prior chemotherapies was 2 (range 1-6). Thirteen patients had residual nodal disease measuring more than 2 cm and four patients had bulky disease at the time of HSCT. Six patients had refractory disease at transplantation. At a median follow-up of 38 months, 3-yr progression-free survival following autologous HSCT was 40%. The 3-yr overall survival was 52%. The cumulative incidence of relapse and non-relapse mortality rate was 41% and 25%, respectively. | lld:pubmed |
| pubmed-article:18774954 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18774954 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18774954 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18774954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18774954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18774954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18774954 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18774954 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18774954 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18774954 | pubmed:issn | 1600-0609 | lld:pubmed |
| pubmed-article:18774954 | pubmed:author | pubmed-author:DevineSteven... | lld:pubmed |
| pubmed-article:18774954 | pubmed:author | pubmed-author:PorcuPierluig... | lld:pubmed |
| pubmed-article:18774954 | pubmed:author | pubmed-author:LinThomas STS | lld:pubmed |
| pubmed-article:18774954 | pubmed:author | pubmed-author:BlumKristie... | lld:pubmed |
| pubmed-article:18774954 | pubmed:author | pubmed-author:HamadaniMehdi... | lld:pubmed |
| pubmed-article:18774954 | pubmed:author | pubmed-author:BensonDon... | lld:pubmed |
| pubmed-article:18774954 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18774954 | pubmed:volume | 81 | lld:pubmed |
| pubmed-article:18774954 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18774954 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18774954 | pubmed:pagination | 425-31 | lld:pubmed |
| pubmed-article:18774954 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:meshHeading | pubmed-meshheading:18774954... | lld:pubmed |
| pubmed-article:18774954 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18774954 | pubmed:articleTitle | High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma. | lld:pubmed |
| pubmed-article:18774954 | pubmed:affiliation | Department of Internal Medicine, Division of Hematology-Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. mehdi.hamadani@gmail.com | lld:pubmed |
| pubmed-article:18774954 | pubmed:publicationType | Journal Article | lld:pubmed |
